维普中文期刊产品整合服务
72篇 您的检索式:作者名="BERND P"
    题名 作者 年代 出处 被引量
1Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival显示文摘BACKGROUND: In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified according to their clinical status and tumor extent to different regional modalities or to best supportive care. The present study evaluated all patients who were stratified to repeated transarterial chemoembolization (TACE) from 1999 until 2003 in terms of tumor response, toxicity, and survival. A moderate embolizing approach was chosen using a combination of degradable starch microspheres (DSM) and iodized oil (Lipiodol) in order to combine anti-tumoral efficiency and low toxicity. METHODS: Fourty-seven patients were followed up prospectively. TACE treatment consisted of cisplatin (50 mg/m2), doxorubicin (50 mg/m2), 450-900 mg DSM, and 5-30 ml Lipiodol. DSM and Lipiodol were administered according to tumor vascularization. Patient characteristics,toxicity, and complications were outlined. In multivariate regression analyses of pre-treatment variables from a prospective database, predictors for tumor response and survival after TACE were determined. RESULTS: 112 TACE courses were performed (2.4±1.5 courses per patient). Mean maximum tumor size was 75 (± 43) mm, in 68% there was bilobar disease. Best response to TACE treatment was: progressive disease (PD) 9%, stable disease (SD) 55%, partial remission (PR) 36%, and complete remission (CR) 0%. Multivariate regression analyses identified tumor size ≤75 mm, tumor number ≤5, and tumor hypervascularization as predictors for PR. The overall 1-, 2-, and 3-year-survival rates were 75%, 59%, and 41%, respectively, and the median survival was 26 months. Low α-fetoprotein levels (<400 ng/ml) (Odds ratio=3.3) and PR as best response to TACE (Odds ratio=6.7) were significantly associated with long term survival (>30 months, R2=36%). Grade 3 toxicity occurred in 7.1% (n=8), and grade 4 toxicity in 3.6% (n=4) of all courses in terms of reversible leukopenia and thrombocytopenia. The incidence of major complications was 5.4% (n=6). All complications were managed conservatively. The mortality within 6 weeks after TACE was 2.1% (one patient). CONCLUSIONS: DSM and Lipiodol were combined successfully in the palliative TACE treatment of advanced HCC resulting in high rates of tumor response and survival at limited toxicity. Favourable tumor response was associated with tumor extent and vascularization. TACE using DSM and Lipiodol can be considered a suitable palliative measure in patients who might not tolerate long acting embolizing agents.Timm D Kirchhoff Joerg S Bleck Arne Dettmer Ajay Chavan Herbert Rosenthal Sonja Merkesdal Bernd Frericks Lars Zender Nisar P Malek Tim F Greten Stefan Kubicka Michael P Manns Michael Galanski 2007Hepatobiliary & Pancreatic Diseases International2007,6,3:15
2Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection - A prospective cross-sectional study显示文摘AIM: Chemokines and their receptors are crucial for immune responses in HCV and HIV infection. RANTES gene polymorphisms lead to altered gene expression and influence the natural course of HIV infection. Therefore,these mutations may also affect the course of HIV/HCV coinfection.METHODS: We determined allele frequencies of RANTES-403 (G→A), RANTES-28 (C→G) and RANTESIN1.1 (T→C) polymorphisms using real-time PCR and hybridization probes in patients with HIV (n = 85), HCV (n= 112), HIV/HCV coinfection (n = 121), and 109 healthy controls. Furthermore, HIV and HCV loads as well as CD4+ and CD8+ cell counts were compared between different RANTES genotypes.RESULTS: Frequencies of RANTES-403 A, RANTES-28 G and RANTES-IN1.1 C alleles were higher in HIV infected patients than in healthy controls (-403: 28.2% vs 15.1%,P = 0.002; -28: 5.4% vs 2.8%, not significant; IN1.1:19.0% vs 11.0%, P = 0.038). In HIV/HCV coinfected patients, these RANTES alleles were less frequent than in patients with HIV infection alone (15.4% P = 0.002;1.7%; P = 0.048; 12.0%; not significant). Frequencies of these alleles were not significantly different between HIV/HCV positive patients, HCV positive patients and healthy controls.CONCLUSION: All three RANTES polymorphisms showed increased frequencies of the variant allele exclusively in patients with HIV monoinfection. The finding that the frequencies of these alleles remained unaltered in HIV/HCV coinfected patients suggests that HCV coinfection interferes with selection processes associated with these alleles in HIV infection.Golo Ahlenstiel Agathe Iwan Jacob Nattermann Karin Bueren Jürgen K Rockstroh Hans H Brackmann Bernd Kupfer Olfert Landt Amnon Peled Tilman Sauerbruch Ulrich Spengler Rainer P Woitas 2005World Journal of Gastroenterology2005,11,48:3
3Shippers' ecological buying behavior towards logistics services in France显示文摘BERND P DORIN M 2011International Journal of Logisties: Research & Applications2011,14,6:1
4Time domain modeling of axisymmetric wave propagation in isotropic elastic media with CEFIT-cylindrical elastodynamic finite integration technique 显示文摘FRANK S BERND K ALEXANDER P 2001Journal of Computational Acoustics2001,9,3:1
5Analysis of the dynamics in microactuators using high-speed cine photomicrography显示文摘Christian Rembe Bernd Tibken Eberhard P Hofer 2001Journal of Microelectromechanical System2001,10,1:1
6Cell density-dependent regulation:Basic principles and effects on the virulence of Gram-positive cocci显示文摘Andreas P Bernd K 2004Int J Infect Dis2004,8,2:1
7The prospects for willow plantations for wastewater treatment in Sweden显示文摘B?rjesson P Berndes G 0,,:1
8Permutation entropy, a natural complexity measure for time series 显示文摘CHRISTOPH B BERND P 2002Physical Review Letters2002,88,17:1
9Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial显示文摘Thomas K?hnlein Wolfram Windisch Dieter K?hler Anna Drabik Jens Geiseler Sylvia Hartl Ortrud Karg Gerhard Laier-Groeneveld Stefano Nava Bernd Sch?nhofer Bernd Schucher Karl Wegscheider Carl P Criée Tobias Welte 2014The Lancet Respiratory Medicine2014,,9:1
10Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination 显示文摘TOTH P BERND R 2014Rev Bras Reumatol2014,5,2:1
11Permutation entropy:a natural complexity measure for time series显示文摘CHRISTOPH B BERND P 2002Physical Review Letters2002,88,17:1
12The structures of the active center in dark-adapted bacteriorhodopsin by solution-state NMR spectroscopy显示文摘HEIKO P BERND S ANTONIUSTER L 2002PANS2002,99,15:1
13TRPV4 calcium entry channel: A paradigrm for gating diversity 显示文摘Bernd N Jolis V Jean P 2004Am J Physiol2004,286,:1
14Evolution of organic matter and nitrogen during co-composting of olive mill wastewater with solid organic wastes显示文摘Paredes C Roig A Bernd M P 2000Biol Fertil Soils2000,32,:1
15Cerebral resuscitation potentials for cardiac arrest显示文摘Safar P Behringer W Bernd W B 2002Crit Care Med2002,30,4:1
16Plastic deformation with reversible peak broadening in nanocrystalline nickel显示文摘BUDROVIC Z van SWYGENHOVEN H DERLET P M van PETEGEM S BERND S 2004Science2004,304,:1
17Neural networks for multiuser detection in code-division multiple-access communications显示文摘 Bernd P P Orsak G 1992IEEE Trans on Commun1992,40,:1
18Aspartokinase genes lysCα and lysCβ overlap and are adjacent to the aspartate β-semialdehyde dehydrogenase gene asd in Corynebacterium glutamicum显示文摘J?rn Kalinowski Bernd Bachmann Georg Thierbach Alfred Pühler 1990MGG Molecular & General Genetics1990,,3:1
19Ultrasonic density sensor for liquids显示文摘Pǜttmer A Peter Hauptmann Bernd Henning 2000IEEE Ultrasonics Symposium2000,47,1:1
20Virtual Labyrinthoscopy: Visualization of the Inner Ear with Interactive Direct Volume Rendering显示文摘Bernd FT Hastreiter P Eberhardt K 2000RadioGraphics2000,20,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费